A Write Up -Capital Ideas ResearchWELL Health Technologies Corp. (TSX:WELL). Eight Capital analyst Christian Sgro has a “Buy” rating and a target price of $13 per share on the technology-enabled healthcare company after WELL completed an oversubscribed $70 million bought deal offering of convertible senior unsecured debentures.
“We expect the company’s decentralized approach to capital allocation to drive accretive M&A growth across all business units as the organic growth story comes more into focus,” the analyst wrote.
“With the additional capital, we believe the company can continue adding scale under all banners while identifying cross-border and cross-sell opportunities to expand reach.”